Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) | MicrobiomeTrials← Back to trialsNCT05652504
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
SUSPENDEDPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2026-11-30
Enrollment target: 400 participants Locations- Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Research Center, Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Mali
Other microbiome trials you might be interested in
Dengue Fever
Background:
Some mosquitos carry viruses that can cause disease. Some examples are dengue and Zika. The mosquitos sprea…
Chbar Mon, Kampong Speu, CambodiaCompleted Jan 25, 2022
Malaria
This randomized, double-blind, placebo-controlled, Phase 1 trial will enroll up to 22 malaria-naïve, adult participants …
Seattle, United StatesEst. completion Feb 1, 2027